INTRODUCTION
Synapses in the central nervous system are sites of communication and anatomical connectivity. Constituent molecules involved in the latter likely include members of the adhesion receptor classes responsible for forming and maintaining junctional contacts between many types of cells (McDonald, 1989; Akiyama et al., 1990) . Two such classes of particular interest are: (i) the immunoglobulin superfamily and (ii) the integrin family of transmembrane matrix receptors which mediate a broad spectrum of cell-cell and cell-substrate interactions (Albelda & Buck, 1990) . Neural cell-adhesion molecules ('NCAMs') of the immunoglobulin class are enriched in synapses (Persohn et al., 1989) , though they are known to be expressed on the plasma membrane throughout the neuron (Pollerberg et al., 1987) . In contrast, little has been established about the localization of integrins in the brain. Fibronectin binds to brain synaptic membrane fractions (Bahr et al., 1991a) and antibodies against the ac,,f1 integrin (the mammalian fibronectin receptor) or the a,z/3 integrin (vitronectin receptor) label different proteins that are highly concentrated in these fractions (Bahr et al., 1991a,b) . It is noteworthy that these proteins are smaller than known integrins. Evidence implicating integrin-like receptors in synaptic function was obtained in two studies showing that peptides which block a subclass of integrins (Ruoslahti & Pierschbacher, 1987) disrupt the stabilization of synaptic potentiation in hippocampal slices (Staubli et al., 1990; Xiao et al., 1991) .
The above results raise the possibilities (i) that synaptic membranes bind to matrix proteins, and (ii) do so via one or more unusual integrin-like adhesion receptors. The present experiments explored these points. Adhesion between synaptosomal membranes and various matrix proteins was tested by seeding the former on to monolayers of the latter. The possibility that any interactions were dependent upon the membranes recognizing the Arg-Gly-Asp (RGD) sequence to which some integrins bind was tested by using matrix proteins lacking the sequence or by including RGD-containing peptides in the assays to competitively block the binding site. A second series of studies was then carried out to identify synaptosomal membrane receptor(s) for fibronectin or related matrix constituents. Solubilized membranes were applied to fibronectin affinity columns, and the material selectively displaced by RGD-containing peptide was collected and analysed. Two proteins appearing as a 55/ 51 kDa doublet recognized by antibodies against the a,l8 integrin were obtained; additional experiments confirmed that this pair of molecules binds to fibronectin. The results provide evidence that brain synaptic membranes contain integrin-like matrix recognition receptors of unusual molecular mass. The proteins identified are thus candidates for elements contributing to the formation, maintenance and modification of synaptic connections.
EXPERIMENTAL

Materials
Polyclonal antibodies (goat anti-gpl40) to the Chinese-hamster ovarian fibronectin receptor (Pytela et al., 1985; Schreiner et al., 1989; Schwarz et al., 1989) were generally provided by Dr. R. L. Juliano (Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, NC, U.S.A.). The peptide Arg-Gly-Asp-Ser (RGDS) was purchased from Bachem (Torrance, CA, USA). Falcon 3912 MicroTest III flexible microtitre plates [poly(vinyl chloride)] were obtained from Becton Dickinson Labware (Oxnard, CA, U.S.A.). Precast acrylamide gradient mini-gels, nitrocellulose paper, and alkaline phosphatase-conjugated antibodies to rabbit, mouse or goat IgGs were from Bio-Rad Laboratories (Richmond, CA, U.S.A.). Gly-Arg-Gly-Asp-Ser-Pro (GRGDSP), human plasma fibronectin and its 45 kDa a-chymotryptic fragnent, and fibronectin-agarose were from Calbiochem Corp. (San Diego, CA, U.S.A.). Leupeptin and polyclonal antibodies against the avA3 vitronectin receptor from human placenta were obtained from Chemico International (Temecula, CA, U.S.A.). Quantigold protein assay reagent was obtained from Diversified Biotech (Newton Centre, MA, U.S.A.). Gly-Arg-Gly-Glu-Ser-Pro (GRGESP), Gly-penicillaminyl-Gly-Arg-Gly-Asp-Ser-Pro-CysAla (GPenGRGDSPCA), human vitronectin, and a monoclonal antibody against the human av integrin subunit were purchased from Telios Pharmaceuticals (San Diego, CA, U.S.A.). Mouse laminin, polyclonal antibodies (Anti-keratin) against fetal-bovine keratin, alkaline phosphatase-conjugated antibodies to guinea pig IgG, a monoclonal antibody (anti-synaptophysin) against synaptophysin from rat synaptosomes, and n-octyl /I-D-glucopyranoside were Synaptic-plasma-membrane isolation Synaptic plasma membranes (SPMs) were prepared from adult male rats (Sprague-Dawley) as previously described . Briefly stated, this involved differential-sedimentationvelocity pelleting, buoyant-density centrifugation in Percoll gradients, and hypo-osmotic lysis. The SPMs were suspended at 2-4 mg of protein/ml in Buffer A consisting of 35 mm-Tris, pH 7.4, 0.05 mM-EDTA and broad-spectrum proteinase inhibitors [antipain, 20 ,ug/ml; aprotinin, 2 ,ug/ml; calpain inhibitor I, 40 ,ug/ml; leupeptin, 2 ,ug/ml; pepstatin A, 2 ,ug/ml; fresh phenylmethane sulphonyl fluoride, 35,ug/ml; N-tosyl-L-phenylalanylchloromethane ('TPCK'), 20 tg/ml divided into aliquots, and stored at -70 'C. The protein content was determined using the Bradford (1976) assay with BSA as standard.
Micro-well adhesion assay
Protein immobilization. Vitronectin, laminin, BSA and fibronectin (or its 45 kDa proteolytic fragment) were immobilized on microtitre plates as previously described (Tomaselli et al., 1987) . In brief, pure protein was diluted in plate adhesion buffer (PAB; composed of Buffer A with 150 mM-NaCl, I mM-CaCl2, 1 mmMgCl2 and 0.02 % NaN3) to a final concentration of 10-150 ,ug/ml, added to wells of a poly(vinyl chloride) plate, allowed to bind for 12-16 h at 23 'C, and then 3 % (w/v) non-fat dry milk was incubated with the pure protein for 2 h at 37 'C to block unoccupied sites on the surface of the microwells. Before milk blocking, control plates were washed with PAB and the extent of surface coating was determined using the nanogramsensitive Quantigold colorimetric protein assay. The colorimetric analyses of the different proteins coated could be compared, since each protein exhibited a similar abosrbance-change-versusprotein-concentration relationship.
SPM adhesion. After four 3 min washes with PAB at 23 'C, adhesion was initiated by adding SPMs (15 ,tg of protein in 0.1 ml of PAB), prepared from whole brain, forebrain or hippocampus, to each well. The plate was incubated for 12 h at 4 'C in the absence or presence of potential adhesion inhibitors, after which three rapid washes with 0.2 ml of ice-cold PAB were used to remove unbound SPMs by aspiration. Bound membranes were fixed to the plate overnight with 3 % (w/v) paraformaldehyde in PAB at 4°C in order to avoid loss of adhered SPMs due to extensive washing steps in subsequent procedures. In early work, bound SPMs were determined with an e.l.i.s.a. method utilizing an antibody against the structural protein keratin, which we have shown to react with a proteoglycan concentrated in rat brain SPMs (Capaldi et al., 1991) . Later work used an antibody to the synaptic-vesicle marker synaptophysin, which is found in virtually all nerve terminals in brain (Navone et al., 1986) . The e.l.i.s.a. procedure entailed (1) thoroughly washing the fixed plate, (2) blocking the wells with 3 % (w/v) non-fat dry milk and (3) incubating with antibody diluted 1: 150 in Tris-buffered saline (30 mM-Tris/200 mM-NaCI), pH 7.4, with 2% (w/v) milk at 4°C for 12-16 h. Secondaryantibody incubation and colour development utilized alkaline phosphatase-conjugated antibodies and the p-nitrophenyl phosphate substrate system. Quantitative immunoreactivity was determined by measuring the A405 using a microplate reader (Molecular Devices Thermo.max). The background immunoreactivity obtained from similarly treated control wells containing no SPM protein was subtracted from all data.
Affinity chromatography
Hippocampal SPMs at 0.8 mg of protein/ml were solubilized in ice-cold PAB with either 150 mM-n-octyl /?-D-glucopyranoside or 1 % (w/v) Triton X-100. Each membrane suspension was homogenized in an etched-glass Potter-Elvehjem tissue grinder for 30 s at high speed, then placed on ice for 1 h. The particulate matter was removed by centrifugation at 50 400 g for 25 min at 4°C, after which the supernatant was divided into portions and stored at -70 'C. The human plasma fibronectin-agarose column was equilibrated at 4 'C in PAB with the respective detergent (30 mM-n-octyl /J-D-glucopyranoside or 0.1 % Triton X-100), which solubilized the SPMs before loading. A portion of solubilized membranes was thawed, diluted with an equal volume of ice-cold PAB, and applied to a 1 cm x 4 cm or 1.5 cm x 7 cm column over a 1 h period at 4 'C. The column was subsequently washed with 5-10 column vol. of the respective equilibration buffer, after which solutions with GRGESP (control peptide) and then with GRGDSP were applied to the column. Individual or pooled fractions ofthe eluant were concentrated to appropriate volumes with Centricon-10 concentrators (Amicon, Danvers, MA, U.S.A.) before electrophoresis and immunoblotting steps.
Electrophoresis and immunoblotting
For Western-blot analysis, samples were treated with 2.5 % (w/v) SDS in the absence or presence of 50 mM-dithiothreitol at 100°C for 5 min, then subjected to PAGE (Laemmli, 1970) . Linear acrylamide gradient [3-17 or 4-15 (w/v)] gels were used to separate proteins, after which the proteins were either silverstained (Merril et al., 1981) or transferred to nitrocellulose (0.2 /4m pore size) as described by Burnette (1981) for 6-12 h.
Incubation of the nitrocellulose with anti-gpl40 (diluted 1: 3000) or with polyclonal (1:1000) or monoclonal (1:300) antibodies against the avc/3 integrin in Tris-buffered saline, pH 7.4, with 0.1 % (v/v) Tween-20 and 1.5 % (w/v) non-fat dry milk, was carried out at 4°C with agitation for 12-16 h. Secondaryantibody incubation and colour development utilized alkaline phosphatase-conjugated antibodies and the 5-bromo-4-chloroindol-3-yl phosphate and Nitroblue Tetrazolium substrate system. Calibration of gels and immunoblots using prestained protein molecular-mass standards allowed size determination for pertinent species.
integrin fibronectin-binding site cause about half of the membranes to remain in solution above the fibronectin monolayer (Table 2 ). This loss is equal to the extent to which integrin attachment to fibronectin monolayers is blocked by RGD peptide (Pytela et al., 1985) . It is not surprising that a significant amount of SPM adhesion still remains under the above two conditions, since RGD-independent interactions exist between fibronectin and other extracellular components, including proteoglycans (Hakomori et al., 1984; Ruoslahti, 1988 Ruoslahti, , 1989 McDonald, 1989) . Table 2 also shows that 1.5 mM-GRGDSP is more effective at inhibiting fibronectin attachment than 3 mM-RGDS; this is similar to the relative potencies reported by Pierschbacher & Ruoslahti (1984) . Note that RGD peptides are only partial antagonists (Ruoslahti & Pierschbacher, 1987) and hence are effective at relatively high concentrations. A control peptide lacking the complete RGD sequence (GRGESP) did not decrease the attachment of synaptic membranes. The SPM-fibronectin association is apparently via a ligand-specific receptor, since the vitronectin-specific peptide inhibitor GPenGRGDSPCA, which is cyclized via a disulphide bridge between the penicillamine (Pen) and the half-cystine, was only weakly effective at blocking
RESULTS
To screen for adhesion molecules in synaptic contacts, we used a simple test in which lysed SPMs were seeded on to microtitre plates coated with a particular matrix component. As a control, protein analyses of coated microwells were carried out. Vitronectin exhibited moderate surface coating, whereas all other proteins tested had good coating efficiencies (Table 1) . As Fig. 1 shows, synaptic membrane fractions adhere to plates coated with fibronectin or vitronectin, but not to those covered with a laminin monolayer. The membrane adhesion is dependent upon the concentration of matrix protein during coating and is saturable. Vitronectin monolayers appear to allow the adherence of more SPMs at higher coating concentrations than do monolayers of fibronectin. This was unexpected, since vitronectin coats plate surfaces four or five times less efficiently than does fibronectin. Similar results were obtained when the adhesion response was measured by using one of two antibodies: (i) antikeratin, which recognizes a high-molecular-mass (400-600 kDa) heparin-binding keratan sulphate proteoglycan that displays tissue-specific localization to brain synaptic membranes (Capaldi et al., 1991) or (ii) anti-synaptophysin, which reacts with a universal synaptic-vesicle marker that is shuttled between vesicular and plasma membranes via exocytotic-endocytotic cycles (Lowe et al., 1988; Valtorta et al., 1988 Valtorta et al., , 1989 Torri-Tarelli et al., 1990 ) and reacts intensely with a 38 kDa protein in immunoblots of the lysed synaptosomal membranes used here (results not shown). Interestingly, hippocampal SPMs consistently displayed 40-50 % more fibronectin attachment/,ug of membrane protein over that displayed by SPMs prepared from whole brain tissue. The anti-keratin e.l.i.s.a. activity from the adhered SPMs accounted for 45.5 + 1.4 % (mean + S.D.; n = 5) and 29.9 + 3.0 % (n =4) of that exhibited by the total SPMs from hippocampus and whole brain respectively that were applied to the microwells and subsequently fixed (without prior washing steps) and assayed as described in the Experimental section.
Two lines of evidence indicate that the adhesion response involves RGD-selective receptors: (i) Fig. 1(a) shows that synaptic membranes do not attach well to a gelatin-binding fibronectin fragment lacking the RGD sequence (FN45; Pierschbacher et al., 1981) , even though the fragment appears to coat surfaces better than fibronectin itself does ( n-octyl f8-D-glucopyranoside and applied to an equilibrated fibronectin-agarose column (3 ml bed volume) as described in the Experimental section. The column was subsequently washed and 2.5 mM-GRGESP or -GRGDSP was added to the elution buffer where indicated by arrows for one column volume. Fractions (1 ml) were collected, and portions of each were analysed by SDS/PAGE under reducing conditions, after which the gels were either silverstained or electroblotted to nitrocellulose for Western-blot analysis (see the Experimental section). The top of the gel, the dye front, and molecular-mass (M) standards from 26.6 to 200 kDa are shown. The molecular masses of relevant bands are shown on the right with arrows. Similar results were obtained with four other SPM preparations from forebrain.
SPM-fibronectin adhesion (Table 2) ; this peptide did block SPM-vitronectin attachments by 30 % (results not shown).
In an effort to identify the proteins responsible for adhesion, we subjected detergent-solubilized hippocampal synaptic membranes to affinity chromatography on fibronectin-agarose. After the column was washed thoroughly, sequential column volumes of solutions with GRGESP (control peptide) and then GRGDSP were applied to the column. The eluted proteins were separated by SDS/PAGE and the resultant gels stained with silver; a typical result is shown in Fig. 2(a) . No bound proteins were displaced by control peptide, whereas a doublet consisting of 55 and 51 kDa polypeptides was eluted by the RGD-containing peptide (lanes 17-19). These polypeptides are not interlinked by disulphide bonds in their native form, since the absence of reducing agents had no effect on their electrophoretic mobilities. As shown in the immunoblot in Fig. 2(b) Fig. 3 .-Isolated F55 re-applied to fresh fibronectin-agarose Forebrain SPMs (3.5 of protein) were solubilized with Triton X-100 and applied to an equilibrated fibronectin-agarose column (12 ml bed volume) as described in the Experimental section. The column was washed thoroughly, then sequentially eluted with 3 mM-GRGESP (lane 1) and 3 mM-GRGDSP (lanes 2 and 3). F55 was eluted with the RGD-containing peptide, and the peak fractions were pooled, diluted 3-fold with equilibration buffer and applied to an unused fibronectin-agarose column (2.5 ml bed volume). Fractions were collected containing the breakthrough volume (lane 4), subsequent washes, and each of two 2.5 ml elutions with 2.5 mM-GRGESP (lane 5) then with 2.5 mM-GRGDSP (lane 6 (Bahr et al., 1991a) . Additional immunoreactivity not seen in previous SPM preparations was evident, probably because of non-specific secondary-antibody reactivity towards the heavy load ofhigh-molecular-mass proteins in lanes 4 and 5. The anti-gpl40 antibodies did not label any antigens in the molecular-mass range of F55 and F40 in tissue homogenates from rat lung, liver, spleen, kidney, adrenal gland, heart or intestinal lining (results not shown).
In order to determine whether the F55 species interacts independently with immobilized fibronectin, GRGDSP-eluted F55 (Fig. 3, lanes 2 and 3) from affinity-chromatographic isolation was concentrated and re-applied to a fresh fibronectin-agarose column. Fig. 3 shows that all of the re-applied F55 bound to the new column material, since silver-stained breakthrough fractions were 'clean' (lane 4). Similarly, no silverstained bands were evident when the column was eluted with up to three bed vol. of GRGESP solution (lane 5). The F55 doublet was then specifically eluted with GRGDSP (lane 6). This 'RGD' recovery of F55 was unchanged in the absence of prior elution of the column with GRGESP control peptide. Double silver staining of the polyacrylamide gels revealed that the F55 protein isolated initially was accompanied by faint bands of 75, 41, and 26 kDa (lane 2); these were not evident in the GRGDSP-eluted FSS from the fresh affinity column (lane 6).
DISCUSSION
The F55 is also greatly (20-40-fold) concentrated in SPMs (Bahr et al., 1991a) and is undetectable in many non-neural tissues. However, although these points are suggestive, there is as yet no direct evidence linking the protein to the observed membranefibronectin interaction.
The a5,t/ integrin receptor is found in many types of cells, but is composed of subunit proteins that are considerably larger (Schreiner et al., 1989; Akiyama et al., 1990) than the synaptosomal membrane F55 polypeptides specifically eluted from the fibronectin column. Matrix receptors of small size have been well characterized for fibronectin (Aplin et al., 1981) , laminin (Clegg et al., 1988; Mafune et al., 1990; Tandon et al., 1991) , collagen (Mollenhauer & von der Mark, 1983) and elastin (Mecham et al., 1989) , but these do not appear to utilize the RGD recognition site and hence are not likely to be related to F55. The possibility also exists that F55 is a cleavage product resulting from proteolysis occurring during tissue preparation and SPM purification. That this can occur is suggested by the observation that a 51 kDa species weakly recognized by antibodies to the ac,,/1 integrin appears along with F55 only after affinity chromatography. This suggests that the chromatographic conditions promote digestion of the larger polypeptide to a species that is 10 % smaller and significantly less antigenic. It is also the case that at least one integrin (XITb,f111a) can be cleaved by CNBr to produce either a 54 or 40 kDa fragment containing an RGDbinding domain similar ( > 80 %) in amino acid sequence to a region of the a. subunit (D'Souza et al., 1990) . This is of particular interest in the present context because the antibodies against the a.,1 fibronectin receptor that detect the 55 kDa protein also react with a 40 kDa polypeptide in SPMs (Bahr et al., 1991a) . Specific proteinases may exist, then, that are resistant to the broad-spectrum inhibitors used in the present experiments and that yield the F55 antigens under discussion.
The contributions of integrin-like receptors in SPMs to synaptic functioning is unclear. Prolonged infusion of RGD-containing peptides into slices of adult hippocampus does not produce any evident perturbations of baseline physiology (Staubli et al., 1990; Xiao et al., 1991) , suggesting that RGD-selective receptors are not chiefly responsible for maintenance of connections, at least in the short term. Slices exposed to the RGDcontaining peptides do exhibit one interesting difference from those treated with control peptides, namely a much decreased capacity for sustaining long-term potentiation of synaptic responses (Staubli et al., 1990; Xiao et al., 1991) . These observations raise the possibility that RGD-selective matrix receptors anchor changes in the configuration of the synapse . Whether the matrix recognition molecule described here is involved will require isolation of its endogenous ligands and infusion of their receptor-binding regions into hippocampal slices. Interestingly, however, a5fl1 integrins in resting human Tcells become fully functional as adhesion molecules subsequent to an activation event (Matsuyama et al., 1989; Shimizu et al., 1990) . Perhaps, then, the Ca2+-driven events leading to expression and stabilization of long-term potentiation include the activation of latent adhesion receptors of which F55 may be an example.
